Inhibitory effects of aspirin and indometacin on the growth of Helicobacter pylori in vitro

Chinese Journal of Digestive Diseases

Volumn 3, Issue 4, 2002, Pages 172-177

  Wang, Wei Hong ^a   Hu, Fu Lian ^a   Cy Wong, Benjamin ^b   Berg, Douglas E ^c   Lam, Shiu Kum ^b  

^a PEKING UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amoxicillin; Aspirin; Clarithromycin; Helicobacter pylori; Indometacin; Metronidazole; Non steroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; AGAR; AMOXICILLIN; ANTIINFECTIVE AGENT; CLARITHROMYCIN; INDOMETACIN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM COLONY; BRUCELLA; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLYSIS; DILUTION; DOSE RESPONSE; GRAM STAINING; GROWTH INHIBITION; HELICOBACTER PYLORI; IN VITRO STUDY; INCUBATION TIME; INOCULATION; MICROBIAL MORPHOLOGY; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

EID: 0037002470     PISSN: 14439611     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1443-9573.2002.00098.x     Document Type: Article

References (25)

1. Cederlund H, Mardh P-A. Antibacterial activities of non-antibiotic drugs. J Antimicrob Chemother 1993; 32: 355-65.
2. Cederlund H, Mardh P-A. Antimicrobial activities of N-acetylcysteine and some non-steroidal antiinflammatory drugs. J Antimicrob Chemother 1993; 32: 903-4.
3. Burns JL, Hedin LA, Lien DM. Chloramphenicol resistance in Pseudomonas cepacia because of decreased permeability. Antimicrob Agents Chemother 1989; 33: 136-41.
4. Burns JL, Clark DK. Salicylate-inducible antibiotic resistance in pseudomonas cepacia associated with absence of a pore-forming outer membrane protein. Antimicrob Agents Chemother 1992; 36: 2280-5.
5. Price CTD, O'Brien FG, Shelton BP, Warmington JR, Grubb WB, Gustafson JE. Effects of salicylate and related compounds on fusidic acid MICs in Staphylococcus aureus. J Antimicrob Chemother 1999; 44: 57-64.
6. Shirin H, Moss SF, Stark B, Weinstein IB, Holt PR, Sordillo EM. Inhibition of Helicobacter pylori growth by sulindac. Gastroenterology 2000; 119: A4931.
7. Benaissa M, Babin P, Quellard N, Pezennec L, Cenatiempo Y, Fauchere JL. Changes in Helicobacter pylori ultrastructure and antigens during conversion from the bacillary to the coccoid form. Infect Immun 1996; 64: 2331-5.
8. Bode G, Mauch F, Malfertheiner P. The coccoid forms of Helicobacter pylori. Criteria for their viability. Epidemiol Infect 1993;111:483-90.
9. Shahamat M, Mai U, Paszko-Kova C, Kessel M, Colwell RR. Use of autoradiography to assess viability of Helicobacter pylori in water. Appl Environ Microbiol 1993; 59: 1231-5.
10. Clyne M, Labigne A, Drumm B. Helicobacter pylori requires an acidic environment to survive in the presence of urea. Infect Immun 1995; 63: 1669-73.
11. Scott D, Weeks D, Melchers K, Sachs G. The life and death of Helicobacter pylori. Gut 1998; 43 (Suppl. 1): S56-60.
12. Goodwin CS, Collin MD, Blincow E. The absence of thermoplasmaquinones in Campylobacter pyloridis, and its temperature and PH growth range. Microbiol Lett 1986; 32: 137-40.
13. Goodwin CS, Armstrong JA. Microbiological aspects of Helicobacter pylori (Campylobacter pylori). Eur J Clin Microbiol Infect Dis 1990; 9: 1-13.
14. Meyer-Rosberg K, Scott DR, Rex D. The effect of environmental pH on the proton motive force of Helicobacter pylori. Gastroenterology 1996; 111: 886-900.
15. Moffat AC, Jackson JV, Moss MS, Widdop B. Clarke's Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids, and Post-Mortem Material. The Pharmaceutical Press, London, 1986.
16. Foulds J, Murray DM, Chai T, Rosner JL. Decreased permeation of cephalosporins through the outer membrane of Escherichia coli grown in salicylates. Antimicrob Agents Chermother 1989; 33: 412-17.
17. Rosner JL. Nonheritable resistance to chloramphenicol and other antibiotics induced by salicylates and other chemotactic repellents in Escherichia coli K-12. Proc Natl Acad Sci USA 1985; 82: 8771-4.
18. Rosner JL, Chai T, Foulds J. Regulation of OmpF porin expression by salicylate in Escherichia coli. J Bacteriol 1991; 173:5631-8.
19. Cohen SP, McMurry LM, Levy SB. Mar locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli. J Bacteriol 1988; 170: 5416-22.
20. Cohen SP, Levy SB, Foulds J, Rosner JL. Salicylate induction of antibiotic resistance in Escherichia coli: Activation of the mar operon and a mar-independent pathway. J Bacteriol 1993; 175: 7856-62.
21. Nikaido H, Vaara M. Molecular basis of bacterial outer membrane permeability. Microbiol Rev 1985; 49: 1-32.
22. Morgan DR, Freedman R, Depew CE, Kraft WG. Growth of Campylobacter pylori in liquid media. J Clin Microbiol 1987; 25: 2123-5.
23. Sjöström JE, Laesson H. Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: Effect of PH and urea on the survival of a wild-type strain and a urease-deficient mutant. J Med Microbiol 1996; 44: 425-33.
24. Malanoski GJ, Eliopoulos GM, Ferraro MJ, Moellering RC Jr. Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin. Eur J Clin Microbiol Infect Dis 1993; 12: 131-3.
25. Grayson ML, Eliopoulos GM, Ferraro MJ, Moellering RC Jr. Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents. Eur J Clin Microbial Infect Dis 1989;8:888-9.